Cargando…
Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome
Early reports of coronavirus disease 2019 (COVID‐19) clinical features describe a hypercoagulable state, and recent guidelines recommend prophylactic anticoagulation for patients with COVID‐19 with low‐molecular‐weight heparin, but this would be contraindicated in the presence of heparin‐induced thr...
Autores principales: | Riker, Richard R., May, Teresa L., Fraser, Gilles L., Gagnon, David J., Bandara, Mahesh, Zemrak, Wesley R., Seder, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276726/ https://www.ncbi.nlm.nih.gov/pubmed/32685905 http://dx.doi.org/10.1002/rth2.12390 |
Ejemplares similares
-
Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
por: Riker, Richard R., et al.
Publicado: (2020) -
Heparin: Heparin-induced thrombocytopenia and thrombosis: case report
Publicado: (2020) -
Heparin: Thrombocytopenia and thrombosis: case report
Publicado: (2021) -
Opioid Prescribing Patterns Before, During, and After Critical Illness: An Observational Study
por: Wampole, Chelsea, et al.
Publicado: (2022) -
Intra‐cardiac thrombosis in the setting of heparin‐induced thrombocytopenia
por: Mohamed, Amr
Publicado: (2021)